These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 8603030

  • 1. Role of growth factors, steroid and peptide hormones in the regulation of human prostatic tumor growth.
    Motta M, Dondi D, Moretti RM, Montagnani Marelli M, Pimpinelli F, Maggi R, Limonta P.
    J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):107-11. PubMed ID: 8603030
    [Abstract] [Full Text] [Related]

  • 2. Growth of the androgen-dependent tumor of the prostate: role of androgens and of locally expressed growth modulatory factors.
    Limonta P, Dondi D, Marelli MM, Moretti RM, Negri-Cesi P, Motta M.
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):401-5. PubMed ID: 7626487
    [Abstract] [Full Text] [Related]

  • 3. Growth factors in steroid-responsive prostatic tumor cells.
    Dondi D, Moretti RM, Marelli MM, Motta M, Limonta P.
    Steroids; 1996 Apr; 61(4):222-5. PubMed ID: 8733005
    [Abstract] [Full Text] [Related]

  • 4. Androgen-dependent prostatic tumors: biosynthesis and possible actions of LHRH.
    Limonta P, Moretti RM, Dondi D, Marelli MM, Motta M.
    J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):347-50. PubMed ID: 8043499
    [Abstract] [Full Text] [Related]

  • 5. Luteinizing hormone-releasing hormone agonists interfere with the stimulatory actions of epidermal growth factor in human prostatic cancer cell lines, LNCaP and DU 145.
    Moretti RM, Marelli MM, Dondi D, Poletti A, Martini L, Motta M, Limonta P.
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3930-7. PubMed ID: 8923840
    [Abstract] [Full Text] [Related]

  • 6. Effects of LHRH agonists on the growth of human prostatic tumor cells: "in vitro" and "in vivo" studies.
    Montagnani Marelli M, Moretti RM, Dondi D, Limonta P, Motta M.
    Arch Ital Urol Androl; 1997 Sep; 69(4):257-63. PubMed ID: 9396187
    [Abstract] [Full Text] [Related]

  • 7. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells.
    Seth D, Shaw K, Jazayeri J, Leedman PJ.
    Br J Cancer; 1999 May; 80(5-6):657-69. PubMed ID: 10360641
    [Abstract] [Full Text] [Related]

  • 8. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
    Long BJ, Grigoryev DN, Nnane IP, Liu Y, Ling YZ, Brodie AM.
    Cancer Res; 2000 Dec 01; 60(23):6630-40. PubMed ID: 11118046
    [Abstract] [Full Text] [Related]

  • 9. Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers.
    Gründker C, Völker P, Schulz KD, Emons G.
    Gynecol Oncol; 2000 Aug 01; 78(2):194-202. PubMed ID: 10926802
    [Abstract] [Full Text] [Related]

  • 10. [Androgen regulation of secreted growth factors in prostate carcinoma cell and tumor lines].
    Kellner U, Wagner B, Otto U, Voigt KD, Dietel M, Knabbe C.
    Verh Dtsch Ges Pathol; 1993 Aug 01; 77():124-8. PubMed ID: 7511269
    [Abstract] [Full Text] [Related]

  • 11. Preclinical evaluation of targeted cytotoxic luteinizing hormone-releasing hormone analogue AN-152 in androgen-sensitive and insensitive prostate cancers.
    Letsch M, Schally AV, Szepeshazi K, Halmos G, Nagy A.
    Clin Cancer Res; 2003 Oct 01; 9(12):4505-13. PubMed ID: 14555524
    [Abstract] [Full Text] [Related]

  • 12. Increased expression of heparin binding EGF (HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines.
    Tørring N, Jørgensen PE, Sørensen BS, Nexø E.
    Anticancer Res; 2000 Oct 01; 20(1A):91-5. PubMed ID: 10769639
    [Abstract] [Full Text] [Related]

  • 13. Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP.
    Limonta P, Dondi D, Moretti RM, Maggi R, Motta M.
    J Clin Endocrinol Metab; 1992 Jul 01; 75(1):207-12. PubMed ID: 1320049
    [Abstract] [Full Text] [Related]

  • 14. Luteinizing hormone-releasing hormone agonist limits DU-145 prostate cancer growth by attenuating epidermal growth factor receptor signaling.
    Wells A, Souto JC, Solava J, Kassis J, Bailey KJ, Turner T.
    Clin Cancer Res; 2002 Apr 01; 8(4):1251-7. PubMed ID: 11948140
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory effects of a luteinizing hormone-releasing hormone agonist on basal and epidermal growth factor-induced cell proliferation and metastasis-associated properties in human epidermoid carcinoma A431 cells.
    Huang YT, Hwang JJ, Lee LT, Liebow C, Lee PP, Ke FC, Lo TB, Schally AV, Lee MT.
    Int J Cancer; 2002 Jun 01; 99(4):505-13. PubMed ID: 11992539
    [Abstract] [Full Text] [Related]

  • 16. Luteinizing hormone-releasing hormone agonists interfere with the mitogenic activity of the insulin-like growth factor system in androgen-independent prostate cancer cells.
    Marelli MM, Moretti RM, Dondi D, Motta M, Limonta P.
    Endocrinology; 1999 Jan 01; 140(1):329-34. PubMed ID: 9886842
    [Abstract] [Full Text] [Related]

  • 17. Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop.
    Dondi D, Limonta P, Moretti RM, Marelli MM, Garattini E, Motta M.
    Cancer Res; 1994 Aug 01; 54(15):4091-5. PubMed ID: 8033142
    [Abstract] [Full Text] [Related]

  • 18. Expression of luteinizing hormone-releasing hormone mRNA in the human prostatic cancer cell line LNCaP.
    Limonta P, Dondi D, Moretti RM, Fermo D, Garattini E, Motta M.
    J Clin Endocrinol Metab; 1993 Mar 01; 76(3):797-800. PubMed ID: 8445038
    [Abstract] [Full Text] [Related]

  • 19. [Analysis of anchorage independent growth of human prostate cancer cell line LNCap].
    Hara Y.
    Nihon Hinyokika Gakkai Zasshi; 1992 Sep 01; 83(9):1429-35. PubMed ID: 1434284
    [Abstract] [Full Text] [Related]

  • 20. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor.
    Brass AL, Barnard J, Patai BL, Salvi D, Rukstalis DB.
    Cancer Res; 1995 Jul 15; 55(14):3197-203. PubMed ID: 7606741
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.